Autologous Transplantation of Haematopoietic Stem Cells With Conditioning Including Zevalin + BEAM to Patients Suffering From Refractory Large B-Cell Diffuse Lymphom
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2016
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 04 May 2012 Status changed from recruiting to completed, according to the European Clinical Trials Database.
- 18 Apr 2008 New trial record.